Heliyon · 2023

Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032].

Hernandez et al.

Sauna
Journal
Heliyon
Year
2023
Publication type
Published Erratum
Read the original publication →

Related research